EPIDEMIOLOGY PROFILE OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE (PID) UNDER REGULAR THERAPY WITH OR WITHOUT INTRAVENOUS IMMUNOGLOBULIN (IVIG) REPLACEMENT IN BRAZIL

被引：0
|
作者：
Lawrence, T. C. [1 ]
Scancetti, F. [2 ]
Silva, A. M. R. [3 ]
Goudouris, E. [4 ]
Ouricuri, A. L. [4 ]
Costa-Carvalho, B. T. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Hosp Crianca Dist Fed, Brasilia, DF, Brazil
[3] Univ Fed Pernambuco, Recife, PE, Brazil
[4] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [31] Socioeconomic Impact of Immunoglobulin Replacement Therapy for Primary Immunodeficiency Patients on the Health Public System in Brazil: a Single Center Study
    Carmo, Erico V. S.
    Correa, Mariangela
    Mazzucchelli, Juliana Lessa
    Tavares, Lusinete
    Damasceno, Elaine
    Costa-Carvalho, Beatriz Tavares
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S48 - S48
  • [32] SOCIOECONOMIC IMPACT OF IMMUNOGLOBULIN REPLACEMENT THERAPY FOR PRIMARY IMMUNODEFICIENCY PATIENTS ON THE HEALTH PUBLIC SYSTEM IN BRAZIL: A SINGLE CENTER STUDY
    Carmo, E., V
    Correa, M.
    Mazzucchelli, J., I
    Tavares, L.
    Damasceno, E.
    Costa-Carvalho, B. T.
    VALUE IN HEALTH, 2015, 18 (07) : A878 - A878
  • [33] Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease An Open-Label Prospective Study
    Kasztalska, Karolina
    Ciebiada, Maciej
    Cebula-Obrzut, Barbara
    Gorski, Pawel
    CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 299 - 307
  • [34] OPEN PROSPECTIVE TRIAL INVESTIGATING PHARMACOKINETICS, TOLERABILITY AND SAFETY OF A NEW 10% HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INFUSION (IVIG) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE
    Krivan, G.
    Koenigs, C.
    Bernatowska, E.
    Marodi, L.
    Erdos, M.
    Salama, A.
    Linde, R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 154 - 154
  • [35] Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
    Menzin, Joseph
    Sussman, Matthew
    Munsell, Michael
    Zbrozek, Arthur
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 297 - 302
  • [36] Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment
    Simao-Gurge, R. M.
    Costa-Carvalho, B. T.
    Nobre, F. A.
    Gonzalez, I. G. S.
    de Moraes-Pinto, M. I.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2017, 45 (01) : 55 - 62
  • [37] The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency
    Boluk, Selime Ozen
    Akcal, Omer
    Taskirdi, Ilke
    Haci, Idil Akay
    Kaya, Mehmet Sirin
    Celik, Figen Celebi
    Soyoz, Ozgen
    Karkiner, Canan
    Gulez, Nesrin
    Genel, Ferah
    TRENDS IN PEDIATRICS, 2023, 4 (02): : 103 - 108
  • [38] Differences in Infection Rates Between Outpatient Hospital (OH), Clinic and Home Infusion Settings for Patients with Primary Immunodeficiencies (PID) Receiving Intravenous Immunoglobulin (IVIG) Therapy
    Ito, Diane
    Xiong, Yan
    Ye, Xiaolan
    Li-McLeod, Josephine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 384 - 384
  • [39] Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes
    Alyanakian, MA
    Bernatowska, E
    Scherrmann, JM
    Aucouturier, P
    Poplavsky, JL
    VOX SANGUINIS, 2003, 84 (03) : 188 - 192
  • [40] Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy
    Jolles, Stephen
    Cristea, Victor
    Wahn, Volker
    Debre, Marianne
    Longhurst, Hilary
    Zenker, Othmar
    Peter, Hans-Hartmut
    Borte, Michael
    CLINICAL IMMUNOLOGY, 2010, 135 : S86 - S87
12345